Mantra Bio Stock

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

Sign up today and learn more about Mantra Bio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Mantra Bio Stock

Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.

Funding History

July 2020$25.0M
January 2023$9.0M


Co-Founder and VP Automation

Terry Gaige

Co-Founder and CTO

Katie Planey

Co-Founder and CEO

Alex Mok

Director Board Of Directors

Francisco Gimenez

Board Observer

David Moskowitz

Chief Scientific Officer

Maria Fuentes


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: